-+ 0.00%
-+ 0.00%
-+ 0.00%

Health Source (600380.SH): Mapasisavir capsules obtained drug registration certificate

Zhitongcaijing·12/11/2025 08:41:08
Listen to the news

Zhitong Finance App News, Health Yuan (600380.SH) announced that the company received the “Drug Registration Certificate” approved and issued by the State Drug Administration. The name of the drug is mapaxavir capsules. Mapasisavir capsules (Yilikang®) is the company's innovative new class 1 anti-influenza drug. It is suitable for the treatment of previously healthy adolescents aged 12 and above and patients with simple influenza A and B, excluding patients with a high risk of influenza-related complications.